Upgrade to SI Premium - Free Trial

H.C. Wainwright Reiterates Buy Rating on AnaptysBio (ANAB)

March 31, 2026 6:42 AM
H.C. Wainwright analyst Emily Bodnar reiterated a Buy rating and $66.00 price target on AnaptysBio (NASDAQ: ANAB).The analyst commented: "On ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments